Jaguar Health Inc. (JAGX)
4.61
-0.15 (-3.15%)
At close: Apr 02, 2025, 3:59 PM
4.57
-0.87%
After-hours: Apr 02, 2025, 07:59 PM EDT
Jaguar Health Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
| Revenue | 11.56M | 9.76M | 11.96M | 4.33M | 9.38M | 5.78M | 4.42M | 4.36M | 141.52K | 258.38K | n/a |
| Cost of Revenue | 1.96M | 2.04M | 2.02M | 2.33M | 3.28M | 3.82M | 2.77M | 880.4K | 51.97K | 123.46K | n/a |
| Gross Profit | 9.61M | 7.72M | 9.94M | 2M | 6.11M | 1.96M | 1.65M | 3.48M | 89.56K | 134.92K | n/a |
| Operating Income | -30.83M | -34.29M | -34.41M | -39.07M | -21.3M | -24.95M | -30.82M | -34.25M | -13.59M | -12.45M | -8.32M |
| Interest Income | n/a | n/a | 12.72M | 8.42M | 2.79M | 5.73M | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -39.25M | -41.9M | -48.4M | -52.6M | -33.81M | -38.53M | -32.15M | -35.15M | -14.73M | -16.29M | -8.61M |
| Net Income | -38.49M | -41.3M | -47.45M | -60.25M | -36.79M | -38.54M | -32.15M | -21.97M | -14.73M | -16.29M | -8.61M |
| Selling & General & Admin | 24.02M | 23.05M | 26.7M | 26M | 21M | 20.44M | 22.11M | 14.33M | 6.47M | 6.1M | 4.1M |
| Research & Development | 16.54M | 18.6M | 17.65M | 15.08M | 6.41M | 5.82M | 5.15M | 4.27M | 7.21M | 6.48M | 4.22M |
| Other Expenses | n/a | 371K | 950K | -765K | 190K | 648.8K | 315.69K | 88.55K | -11.05K | -27.28K | n/a |
| Operating Expenses | 40.56M | 42.02M | 44.35M | 41.08M | 27.41M | 26.91M | 27.26M | 18.6M | 13.68M | 12.58M | 8.32M |
| Interest Expense | -231K | 6.38M | 12.72M | 8.42M | 2.79M | 5.73M | 2.63M | 1.21M | 985.55K | 3.32M | n/a |
| Selling & Marketing Expenses | 7.69M | 6.46M | 8.84M | 8.89M | 6.61M | 6.94M | 9.83M | 3.08M | 485.44K | 765.09K | n/a |
| Cost & Expenses | 42.52M | 44.05M | 46.37M | 43.41M | 30.69M | 30.72M | 30.03M | 19.48M | 13.73M | 12.7M | 8.32M |
| Income Tax | -759K | n/a | -941K | 7.65M | 2.98M | 10K | -1.28M | -13.18M | 1.14M | 3.82M | 345.34K |
| Shares Outstanding (Basic) | 294.53M | 384.47K | 1.31M | 596.15K | 171.75K | 22.07K | 2.07K | 806.00 | 59.00 | 34.00 | 42.00 |
| Shares Outstanding (Diluted) | 294.53M | 384.47K | 1.31M | 596.15K | 171.75K | 22.07K | 2.07K | 806.00 | 59.00 | 34.00 | 42.00 |
| EPS (Basic) | -0.13 | -107.42 | -36.18 | -101.07 | -214.22 | -1.75K | -15.51K | -27.26K | -249.73K | -479.16K | -204.99K |
| EPS (Diluted) | -0.13 | -107.42 | -36.18 | -101.07 | -214.22 | -1.75K | -15.51K | -27.26K | -249.73K | -479.16K | -204.99K |
| EBITDA | -30.83M | -33.13M | -33.38M | -42.35M | -28.74M | -30.87M | -27.77M | -11.13M | -13.7M | -12.97M | -8.37M |
| EBIT | -39.48M | -33.92M | -35.67M | -44.18M | -31.02M | -32.8M | -29.52M | -15.12M | -13.59M | -12.97M | -8.26M |
| Depreciation & Amortization | n/a | 1.16M | 2.29M | 1.83M | 2.28M | 1.93M | 1.75M | 584.34K | 47.49K | 5.16K | -51.42K |